" class="no-js "lang="en-US"> Partnerships Archives - Medtech Alert
Monday, February 26, 2024

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]

Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders

Astellas Pharma and Cullgen have announced a research collaboration and exclusive option agreement to discover […]

Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets

Captivate Bio and EverCell Bio are excited to announce a new collaboration to accelerate the development […]

Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies

Applied StemCell and the California Institute for Regenerative Medicine (CIRM) have partnered as Industry Resource […]

Future Fields and Jenthera Therapeutics Collaborate to Develop Novel Protein for the Delivery of Cancer Biologics

Future Fields, a pioneering biotechnology company that has built the world’s first synthetic biology system […]

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration

Charles River Laboratories International and the INADcure Foundation, a nonprofit organization whose mission is to […]

Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases

Quell Therapeutics, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions […]

Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430

Astellas Pharma and Kate Therapeutics have announced an exclusive license agreement to develop and commercialize KT430. […]

Mendus and NorthX Biologics to Enter into Strategic Cell Therapy Manufacturing Alliance Supported by New Investor Flerie

Mendus AB, a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it […]

Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

Axol Bioscience, a leading pluripotent stem cell technology provider for drug discovery has signed an […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more